Electra Therapeutics Statistics

NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

9.16-0.66 (-6.72%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Electra Therapeutics by the numbers

Electra Therapeutics has a market capitalization of $574.9 million based on 62.77M shares outstanding. With trailing EPS of $-2.65, Electra Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.3% below its 50-day average and 21.3% below its 200-day average.

Average daily trading volume is 990.55K shares, or about $9.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ETRA valuation vs. peer median

ETRA compared with the median of 8 peer companies
Metric	ETRA	Peer median	Difference
Market cap	$574.95M	$585.32M	-2%
Avg. volume	990.55K	1.12M	-11%

Peer median across 8 companies: VALN, DBVT, PROK, RGNX, ALLO, AUTL, AURA, FDMT.

Valuation

Market cap: $574.95M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-2.65
Shares outstanding: 62.77M

Price and trading

Previous close: 9.82
Open: 9.73
Day range: 8.92 – 9.73
52-week range: 8.92 – 15.50
50-day moving average: 11.64
200-day moving average: 11.64
Beta: —
Volume: 407.26K
Average volume: 990.55K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 574.95M
Eps: -2.65
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 15.50
Week52 Low: 8.92
Avg Volume: 990.55K
Shares Outstanding: 62.77M
Ma50: 11.64
Ma200: 11.64
Pct From52w High: -40.90%
Pct From52w Low: 2.69%